Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins.

Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins. Clin Cancer Res. 2011 Sep 01; 17(17):5748-54.

View in: PubMed

subject areas

Adaptor Proteins, Signal Transducing
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Dacarbazine
DNA Damage
DNA Mismatch Repair
Female
Humans
Male
Middle Aged
MutL Protein Homolog 1
MutS Homolog 2 Protein
Mycosis Fungoides
Nuclear Proteins
O(6)-Methylguanine-DNA Methyltransferase
Sezary Syndrome
Treatment Outcome

authors with profiles

Mary Eileen Dolan